Abstract: Collagen, particularly atelopeptide collagen, exhibits improved handling characteristics when chemically conjugated and/or crosslinked with a synthetic hydrophilic polymer.

Abstract: Stress-bearing prostheses for replacement or partial replacement of stress-bearing bone are fixed in place by bony ingrowth by providing a stress-bearing member having a porous region in combination with an osteogenic factor extract or a purified osteogenic inductive protein, optionally in combination with a TGF-beta cofactor, in a pharmaceutically acceptable carrier. The carrier is preferably either a collagen composition or a ceramic.

Abstract: DNA sequences encoding .beta.-amyloid-related proteins associated with Alzheimer's disease are disclosed. Also provided herein is a DNA sequence encoding a novel protease inhibitor. These sequences are used in producing or constructing recombinant .beta.-amyloid core protein, .beta.-amyloid-related proteins and recombinant or synthetic immunogenic peptides. Antibodies generated against the recombinant proteins or immunogenic peptides derived therefrom can be used for cerebral fluid or serum protein diagnosis of Alzheimer's disease.

Abstract: Ligands in the form of N-acetyllactosamines which bind to endothelial leukocyte adhesion molecule-1 (ELAM-1) are disclosed. The ligand compounds can be formulated into pharmaceutical compositions and/or assay compositions used to alleviate inflammation and assay for the presence of (qualitative) and amount of (quantitative) ELAM-1 and thereby determine the presence, location and degree of inflammation.

Abstract: Ligands in the form of N-acetyllactosamines which bind to endothelial leukocyte adhesion molecule-1 (ELAM-1) are disclosed. The ligand compounds can be formulated into pharmaceutical compositions and/or assay compositions used to alleviate inflammation and assay for the presence of (qualitative) and amount of (quantitative) ELAM-1 and thereby determine the presence, location and degree of inflammation. The ligands are encompassed by general structural formula I as follows: ##STR1## wherein one of F and G is hydrogen and one is an N-acetyl neuraminic acid residue on the terminal unit and are both hydrogen on any other unit; J is hydrogen, a lactosylceramide or a linking group and K is hydrogen or a fucose residue and n is an integer of from 1 to 10 (preferably 3 or 4) with the proviso that n and K are defined such that at least one K is a fucose residue.

Abstract: A high-purity II-VI semiconducting compound can be produced by initially preparing a substrate of a II-VI semiconducting compound by a chemical transport method with a halogen as transport medium and then epitaxially growing a layer of a II-VI compound on this substrate.

Abstract: Pyropheophorbide compounds are injected into a host and accumulate in tumor tissue to a higher degree than surrounding normal tissues. When the pyropheophorbide compounds are exposed to a particular wavelength of light the compounds become cytotoxic and destroy the tumor or diseased tissue without causing irreversible normal tissue damage. The pyropheophorbide compounds have shown improved results as compared to drugs currently used in photodynamic therapy. Further, they absorb light further in the red, optimizing tissue penetration and are retained in the skin for short time periods relative to other drugs used in photodynamic therapy.

Abstract: Ligands in the form of N-acetyllactosamines which bind to endothelial leukocyte adhesion molecule-1 (ELAM-1) are disclosed. The ligand compounds can be formulated into pharmaceutical compositions and/or assay compositions used to alleviate inflammation and assay for the presence of (qualitative) and amount of (quantitative) ELAM-1 and thereby determine the presence, location and degree of inflammation. The ligands are encompassed by general structural formula I as follows: ##STR1## wherein one of A and B is hydrogen and one is an N-acetyl neuraminic acid residue; D and E are each independently hydrogen or a fucose residue; n is an integer of from 0 to 10 with the proviso that if n is 0, E is a fucose residue; F is hydrogen, a lactosylceramide residue or a linking group; and molecules equivalent to a compound of formula I regarding its ability to bind to an ELAM-1 receptor to the same degree as a compound of formula I.

Abstract: Stable, clear, antimicrobially effective, ophthalmic formulations include an ophthalmologically effective amount of a drug, especially a --COOH group-containing drug or a NSAID, and a preservative system formed of a quaternary ammonium preservative and a nonionic surfactant, all in an aqueous vehicle. These formulations are useful for treating diseases that are either caused by, associated with or accompanied by inflammatory processes, including, among others, glaucoma, cystoid macular edema, uveitis, diabetic retinopathy and conjunctivitis, or any trauma caused by eye surgery or eye injury.

Abstract: The present invention provides for an explosive composition comprising a discontinuous oxidizer phase comprising at least one oxygen-supplying component, a continuous organic phase comprising at least carbonaceous fuel, and an emulsifying amount of (A) at least one salt composition derived from (A) (I) at least one high-molecular weight hydrocarbyl-substituted carboxylic acid or anhydride, or ester or amide derivative of said acid or anhydride, the hydrocarbyl substituent of (A) (I) having an average of from about 20 to about 500 carbon atoms, and (A) (II) ammonia, at least one amine, at least one alkali or alkaline earth metal, and/or at least one alkali or alkaline earth metal compound; and (B) at least one salt composition derived from (B) (I) at least one low-molecular weight hydrocarbyl-substituted carboxylic acid or anhydride, or ester or amide derivative of said acid or anhydride, the hydrocarbyl substituent of (B) (I) having an average of from about 8 to about 18 carbon atoms, and (B) (II) ammonia, at

Abstract: Intraocular hypertensive diseases such as glaucoma are treated with compounds represented by formula I ##STR1## or a pharmaceutically acceptable acid addition salt thereof, whereinR.sub.1 is alkyl of two to four carbon atoms; andR.sub.2 is alkyl of three or four carbon atoms; orR.sub.1 and R.sub.2 taken together with N form ##STR2## wherein n is 0, 1, or 2 and R.sub.5 and R.sub.6 are each independently lower alkyl or hydro;R.sub.3 is hydro or hydroxy;R.sub.4 is hydro, lower alkyl, amino, or lower alkylamino.

Abstract: A water-in-oil emulsion is disclosed which comprises:(A) a continuous oil phase;(B) a discontinuous aqueous phase;(C) a minor emulsifying amount of at least one salt derived from (C) (I) at least one hydrocarbyl-substituted carboxylic acid or anhydride, or ester or amide derivative of said acid or anhydride, the hydrocarbyl substituent of (C) (I) having an average of from about 20 to about 500 carbon atoms, and (C) (II) ammonia, at least one amine, at least one alkali or alkaline earth metal, and/or at least one alkali or alkaline earth metal compound; and(D) a functional amount of at least one water-soluble, oil-insoluble functional additive dissolved in said aqueous phase; with the proviso that when component (D) is ammonium nitrate, component (C) is other than an ester/salt formed by the reaction of polyisobutenyl (Mn=950) succinic anhydride with diethylethanolamine in a ratio of one equivalent of anhydride to one equivalent of amine.

Abstract: Salt compositions are disclosed which comprise: (A) at least one salt moiety derived from (A)(I) at least one high-molecular weight polycarboxylic acylating agent, said acylating agent (A)(I) having at least one hydrocarbyl substituent having an average of from about 20 to about 500 carbon atoms, and (A)(II) ammonia, at least one amine, at least one alkali or alkaline earth metal, and/or at least one alkali or alkaline earth metal compound; (B) at least one salt moiety derived from (B)(I) at least one low-molecular weight polycarboxylic acylating agent, said acylating agent (B)(I) optionally having at least one hydrocarbyl substituent having an average of up to about 18 carbon atoms, and (B)(II) ammonia, at least one amine, at least one alkali or alkaline earth metal, and/or at least one alkali or alkaline earth metal compound; said components (A) and (B) being coupled together by (C) at least one compound having (i) two or more primary amino groups, (ii) two or more secondary amino groups, (iii) at least one

Abstract: A method for producing homopolymers and copolymers from amido-sulfonic acid or salt containing monomers in the presence of high energy mechanical mixing utilizing a final stage polymerization temperature of from about 200.degree. F. to below the degradation temperature of the monomer. The process produces a solid homopolymer or copolymer which can be utilized as fluid loss agents.

Abstract: Excess amounts of a pure form of acrylonitrile are reacted with other reactants in the production of various compounds such as 2-acrylamido-2-methyl propane sulfonic acid. Accordingly, large amounts of acrylonitrile remain unreacted and present with other contaminants. The present invention is directed toward the purification of such unreacted acrylonitrile and the purified acrylonitrile obtained from such a purification process. The purification is carried out by treating the unreacted acrylonitrile with a base and removing salts formed. The treated material is fed to a heat exchanger which heats the material preferably under vacuum to about 120.degree. F. and provides a heated fluid material. This heated fluid material is pumped to a lower area of a distillation tower which is maintained under vacuum and includes a plurality of distillation trays.

Abstract: This invention is directed to lubricating and functional fluid compositions having improved antioxidant and extreme pressure properties and high temperature stability. The lubricant and functional fluid compositions comprise a major amount of at least one oil of lubricating viscosity and a minor amount of(A) a sulfur compound characterized by the structural formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are each independently H or hydrocarbyl groups;R.sup.1 and/or R.sup.3 may be G.sup.1 or G.sup.2 ;R.sup.1 and R.sup.2 and/or R.sup.3 and R.sup.4 together may be alkylene groups containing about 4 to about 7 carbon atoms;G.sup.1 and G.sup.2 are each independently C(X)R, COOR, C.tbd.N, R.sup.5 --C.dbd.NR.sup.6, CON(R).sub.2 or NO.sub.2, and G.sup.1 also ay be a CH.sub.2 OH group, wherein X is O or S, R.sup.5 and each R are independently H or a hydrocarbyl group, R.sup.6 is H or a hydrocarbyl group;when both G.sup.1 and G.sup.2 are R.sup.5 C.dbd.NR.sup.6, the two R.sup.

Abstract: An asphalt cement mixture is disclosed. The mixture has improved antistripping properties due to the inclusion therein of a minor amount of an antistripping agent produced by the condensation reaction of an amine, an aldehyde or aldehyde reaction synthon an alkylated phenol. The antistripping agent is preferably present in the asphalt cement in an amount of from about 0.25% to about 1% by weight based on the weight of the asphalt cement. The asphalt cement is combined with an aggregate to form a concrete and paved onto a road surface to provide a paved surface with improved durability.

Abstract: Oil based compositions are disclosed which are comprised of oil having a multi-functional additive component therein. The additive component is present in sufficient amounts so as to provide improved performance characteristics to the composition such as water tolerance and antiwear characteristics. The additive is a compound represented by the general structural formula (I): ##STR1## wherein R is a hydrocarbyl, preferably iso-stearyl, R.sub.1, R.sub.2, and R.sub.3 are independently hydrogen or alkyl, preferably hydrogen, n is 1 to 20, preferably 5, and X is a cation, preferably Ca. Overbased and mixed salts of the additive compound are also disclosed. The additive is an effective EP agent, water tolerance fix in a variety of functional fluids and lubricating compositions.

Abstract: Various heterocyclic compounds have been discovered that impart improved fuel economy and friction modification to lubricant and fuel compositions. These hetrocyclic compounds of the invention preferably contain nitrogen and may be further reacted with hydrocarbyl carboxylic acid acylating reactants or hydrocarbyl phenolic reactants to give higher molecular materials. These higher molecular weight materials have higher oil-solubility and impart dispersancy properties to lubricant and fuel compositions.

Abstract: Functional fluids such as metal working fluids are disclosed which include an oil of lubricating viscosity, a sulfurized organic compound, and an amine derivative. The amine derivative is a hindered imine which is the reaction product obtained from reacting a primary amine connected to a tertiary alkyl group with an aldehyde or aldehyde reaction synthon. The inclusion of the hindered imine within the metal working fluid suppresses the generation of hydrogen sulfide gases during the use of the fluid thus improving the environmental and safety characteristics of the fluid.